Search results, if found, will automatically update as terms are selected. If no results are displayed, please revise your search terms.
Filter By:
Li Lily Wang, PhD
Clinical Associate ProfessorDepartment of Molecular MedicineSchool of MedicineMemberImmune Oncology ProgramCase Comprehensive Cancer CenterEmail: wangl9@ccf.org
Phone: 216.973.5628
The Wang laboratory is engaging in cross-disciplinary studies by collaborating with basic and clinical researchers from LRI /CCF and Case Western Reserve University. Immune-checkpoint blockade therapies have revolutionized the field of Cancer Immunotherapy. The Wang laboratory is among the first groups to demonstrate that the immune-checkpoint protein “V domain Immunoglobulin Suppressor of T cell Activation” (VISTA) is a promising target for cancer Immunotherapy. Current projects are multi-disciplinary and involve elucidating the epigenetic and metabolic regulations by novel inhibitory receptors on tumor-associated cytotoxic T cells and tumor-associated macrophages or myeloid derived suppressor cells. We are also investigating the mechanisms of resistance following chimeric antigen receptor (CAR) T cell-based therapies in lymphoma patients.
Rui Wang, PhD
Assistant ProfessorDepartment of SurgerySchool of MedicineMemberMolecular Oncology ProgramCase Comprehensive Cancer CenterEmail: Rui.Wang17@case.edu
Phone: 216.368.5667
We interrogate crosstalks between cancer cells and the microenvironment in metastatic colorectal and pancreatic cancers. For example, the surrounding liver mcrienvironment secretes soluble factors to activate HER3 and other survival pathways in cancer liver metastases. By identifying key survival pathways (such as HER3) ivolved in the crosstalk, we aim to develop therapeutic strategies of disrupting the crosstalk (e.g. block secreted factors, or block HER3 in cancer cells) to inhibit metastatic tumor outgrowth and, and also sensitize cancer cells to standard-of-care treatments for combination therapies.
Bingcheng Wang, PhD
John A. and Josephine B. Wootton Endowed Chair of Research and ProfessorDepartment of MedicineSchool of MedicineProfessorDepartment of PharmacologySchool of MedicineProfessorDepartment of Physiology and BiophysicsSchool of MedicineMemberMolecular Oncology ProgramCase Comprehensive Cancer CenterSchool of MedicineMemberCleveland Center for Membrane & Structural BiologySchool of MedicineEmail: bingcheng.wang@case.edu
Phone: 216.778.4256
I focus on the molecular mechanisms governing cell migration and proliferation, and experimental therapy of cancer metastasis using tumor-targeting peptides.
Ming Wang, PhD
Associate ProfessorDepartment of Population and Quantitative Health SciencesSchool of MedicineDirector, Masters Program in BiostatisticsDepartment of Population and Quantitative Health SciencesSchool of MedicineEmail: mxw827@case.edu
We are interested in statistical method development in data integration and causal inference and collaborative work in biomedical and human health research. We develop computational methods for analyzing and identifying biomarkers from high-dimensional genomic/genetic/imaging data. Also, we work on electronic health record data and other big data in cancer, cardiovascular, kidney and neurodegenerative diseases for decision making and value-based care research.
Wenzhang Wang, PhD
Assistant ProfessorDepartment of PathologySchool of MedicineEmail: wenzhang.wang@case.edu
Phone: 216.368.3753
We are interested in the pathogenesis of neurodegenerative diseases with the focus on the mitochondrial dysfunctions. We utilize the cell culture in vitro and transgenic rodent in vivo models to explores the mechanisms underlying abnormal mitochondria and disturbed brain homeostasis.
Zhenghe J Wang, PhD
Chair and ProfessorDepartment of Genetics and Genome SciencesSchool of MedicineDale H. Cowan M.D. – Ruth Goodman Blum Professor of Cancer ResearchCo-LeaderCancer Genomics and Epigenomics ProgramCase Comprehensive Cancer CenterEmail: zxw22@case.edu
Phone: 216.368.0446
My research program focuses on developing new treatments for colorectal cancer and translating bench discoveries into clinical trials. A particular focus of my research is to understand how oncogenic PIK3CA mutations drive tumorigenesis and design new therapeutic approaches for PIK3CA mutant cancers.
Scott Williams, PhD
ProfessorDepartment of Population and Quantitative Health SciencesSchool of MedicineProfessorDepartment of Genetics and Genome SciencesSchool of MedicineFacultyCleveland Institute for Computational BiologyEmail: smw154@case.edu
Phone: 216.368.5659
I investigate the distribution of genetic variation and the role that this variation plays in phenotypic differences among populations, including the role of host pathogen co-evolution in infectious disease risk.
Mark Willis, PhD
Professor and ChairDepartment of BiologyCollege of Arts and SciencesEmail: mark.willis@case.edu
Phone: 216.368.3557
I research the neural basis of adaptive behavior, odor-guided navigation and flight in insects.
JungA ‘Alexa’ Woo, PhD
Associate ProfessorDepartment of PathologySchool of MedicineEmail: Jaw330@case.edu
Phone: 216.368.0052
Our lab focuses on understanding how beta-arrestins, proteins known to regulate various GPCRs signaling (~40% of FDA-approved drugs target GPCRs), contribute to neurodegeneration in Alzheimer’s disease (AD) and related dementias (ADRD).
Chen-Han Wilfred Wu, MD, PhD
Assistant ProfessorDepartment of Genetics and Genome SciencesSchool of MedicineAssistant ProfessorDepartment of UrologySchool of MedicineDirectorUrogenetics ProgramMemberCancer Genomics and Epigenomics ProgramCase Comprehensive Cancer CenterSchool of MedicineEmail: wilfred.wu@case.edu
Phone: 216.368.0837
Our lab is at the forefront of genomics in urological conditions, leveraging large datasets from both phenotypic information gleaned from electronic medical records (EMR) and genomic data from comprehensive sequencing techniques. We offer the unique experience of working in both dry and wet lab environments, with data access to resources like the UK Biobank, All-of-Us, TriNetX, University Hospitals EMR, and our in-house experiments. Our current active projects span areas such as kidney stones, male infertility, and transgender studies, providing a rich and diverse research environment to advance your academic career.